Nutrition is an important and often overlooked aspect of the oncology treatment paradigm that could significantly impact the health and quality of lif...

The Hong Kong Department of Health has approved tisotumab vedotin-tftv (Tivdak) as a treatment for adults with metastatic or recurrent cervical cancer...

The combination of venetoclax (Venclexta) plus azacitidine did not improve overall survival (OS) compared with placebo plus azacitidine in patients wi...

At the Society of Hematologic Oncology 2025 Annual Meeting, CancerNetwork® spoke with Francesca Palandri, MD, PhD, an adjunct professor in the Departm...

Statistically significant reductions in all-cause mortality, progression to myelofibrosis, and venous thromboembolism (VTE) occurred among patients wi...

Mirvetuximab soravtansine-gynx (Elahere) has been approved by Health Canada as an injection for patients with folate receptor-alpha (FRα)–positive pla...

Patients treated with de-escalated adjuvant radiation therapy (DART) exhibited lower cumulative rates of toxicity vs patients with standard of care th...

Urine glycosaminoglycan profile (GAGome) scores exhibited high sensitivity to detect clear cell renal cell carcinoma (ccRCC) recurrence after surgery,...

Stereotactic ablative radiotherapy (SABR) of uncomplicated bone metastases achieved an encouraging 1-year local control rate with an acceptable toxici...

Researchers at the Children's Hospital of Philadelphia have developed a new strategy to improve the effectiveness of GPC2-directed CAR T-cell therapy...